Polyseq
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $14M
Investors
- 8
About Polyseq
, trading as Polyseq, is a medical and health company focusing on the research and development of nanopore gene sequencing technology. It has partnerships with GHIC, IDG Capital, Tsinghua Innovation Ventures, etc. The company's main business is the research, development, and production of nanopore gene sequencing technology. Based on self-developed nanopore sequencing chemistry and analysis of various novel membrane protein nanopore atomic structures, combined with technologies such as nucleic acid chemistry, protein engineering, artificial membrane construction and characterization, semiconductor integrated circuit chip design, deep learning, and genomics, the firm has developed nucleic acid and other biopolymer sequencing instruments and supporting reagent consumables. The company’s revenue streams are derived from the sale of sequencing instruments, biochips, reagents, and sequencing services for research and clinical applications.
Who invested in Polyseq
8 investors across 3 rounds
See all investors in Polyseq
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Polyseq
Who invested in Polyseq?
Polyseq has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Polyseq raised?
Polyseq has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Polyseq last raise money?
Polyseq's most recent round on record is a Series A, in Nov 2025.
What does Polyseq do?
, trading as Polyseq, is a medical and health company focusing on the research and development of nanopore gene sequencing technology.
Where is Polyseq headquartered?
Polyseq is headquartered in Beijing, China.
Which VCs invest in companies like Polyseq?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Polyseq's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Polyseq? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.